Table 5 Association of the mtDNA D310 variation in bladder cancer patients and controls
Ethnicity | NO. | C 7TC6 | C 8TC6 | C 9TC6 | C 10TC6 |
|---|---|---|---|---|---|
Arab | 23 | 12 (52.2%) | 8 (34.7%) | 2 (8.7%) | 1 (4.3%) |
Armenian | 18 | 7 (38.9%) | 11 (61.1%) | 0 (0%) | 0 (0%) |
Azari | 22 | 8 (36.4%) | 12 (54.5%) | 2 (9%) | 0 (0%) |
Turkmen | 37 | 17 (45.9%) | 16 (43%) | 4 (10.8%) | 0 (0%) |
Bandari | 31 | 10 (32%) | 15 (48.4%) | 6 (19.4%) | 0 (0%) |
Persian Isfahan | 16 | 5 (31.3%) | 9 (56.3%) | 2 (6.5%) | 0 (0%) |
Persian Mashhad | 23 | 14 (60.9%) | 8 (34.8%) | 1 (4.3%) | 0 (0%) |
Persian Shiraz | 23 | 6 (26%) | 16 (69.6) | 1 (4.3%) | 0 (0%) |
Persian Yazd | 24 | 9 (37.5%) | 9 (37.5%) | 5 (20.8%) | 1 (4.1%) |
Guilani | 24 | 8 (33%) | 12 (50%) | 4 (16.6%) | 0 (0%) |
Jews | 37 | 16 (43%) | 17 (45.9) | 4 (10.8%) | 0 (0%) |
Kurd | 24 | 3 (12.5%) | 14 (58%) | 7 (29%) | 0 (0%) |
Lur | 22 | 9 (41%) | 9 (41%) | 4 (18%) | 0 (0%) |
Total (controls) | 324 | 124 (38.3) | 156 (48.1%) | 42 (13%) | 2 (0.6%) |
Patients | 21 | 9 (42.9%) | 10 (47.6%) | 2 (9.5%) | 0 (0%) |